These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 25766618)
1. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Kim B; Feldman EL Exp Mol Med; 2015 Mar; 47(3):e149. PubMed ID: 25766618 [TBL] [Abstract][Full Text] [Related]
2. Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: Is Aβ a Crucial Factor in Both Pathologies? Campos-Peña V; Toral-Rios D; Becerril-Pérez F; Sánchez-Torres C; Delgado-Namorado Y; Torres-Ossorio E; Franco-Bocanegra D; Carvajal K Antioxid Redox Signal; 2017 Apr; 26(10):542-560. PubMed ID: 27368351 [TBL] [Abstract][Full Text] [Related]
3. The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation. Al-Kuraishy HM; Jabir MS; Albuhadily AK; Al-Gareeb AI; Rafeeq MF Ageing Res Rev; 2023 Nov; 91():102084. PubMed ID: 37802319 [TBL] [Abstract][Full Text] [Related]
4. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies]. Joly-Amado A; Gratuze M; Benderradji H; Vieau D; Buée L; Blum D Med Sci (Paris); 2018 Nov; 34(11):929-935. PubMed ID: 30526837 [TBL] [Abstract][Full Text] [Related]
5. Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease. Caccamo A; Belfiore R; Oddo S Neurobiol Aging; 2018 Aug; 68():1. PubMed ID: 29729422 [TBL] [Abstract][Full Text] [Related]
6. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease. Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654 [TBL] [Abstract][Full Text] [Related]
7. Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? Frisardi V; Solfrizzi V; Capurso C; Imbimbo BP; Vendemiale G; Seripa D; Pilotto A; Panza F J Alzheimers Dis; 2010; 21(1):57-63. PubMed ID: 20421697 [TBL] [Abstract][Full Text] [Related]
9. Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma. Johnson LA; Zuloaga KL; Kugelman TL; Mader KS; Morré JT; Zuloaga DG; Weber S; Marzulla T; Mulford A; Button D; Lindner JR; Alkayed NJ; Stevens JF; Raber J EBioMedicine; 2016 Jan; 3():26-42. PubMed ID: 26870815 [TBL] [Abstract][Full Text] [Related]
10. Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential. Sato N; Takeda S; Uchio-Yamada K; Ueda H; Fujisawa T; Rakugi H; Morishita R Curr Aging Sci; 2011 Jul; 4(2):118-27. PubMed ID: 21235496 [TBL] [Abstract][Full Text] [Related]
11. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434 [TBL] [Abstract][Full Text] [Related]
12. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence? Stanley M; Macauley SL; Holtzman DM J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942 [TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link. Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110 [TBL] [Abstract][Full Text] [Related]
14. Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Yates KF; Sweat V; Yau PL; Turchiano MM; Convit A Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2060-7. PubMed ID: 22895667 [TBL] [Abstract][Full Text] [Related]
16. Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation. Kim B; Figueroa-Romero C; Pacut C; Backus C; Feldman EL J Biol Chem; 2015 Jul; 290(31):19146-57. PubMed ID: 26100639 [TBL] [Abstract][Full Text] [Related]
17. Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer's disease. Barron AM; Rosario ER; Elteriefi R; Pike CJ PLoS One; 2013; 8(10):e78554. PubMed ID: 24205258 [TBL] [Abstract][Full Text] [Related]
18. Targeting hypercoagulation to alleviate Alzheimer's disease progression in metabolic syndrome. Khan S; Pati S; Singh S; Akhtar M; Khare P; Khan S; Shafi S; Najmi AK Int J Obes (Lond); 2022 Feb; 46(2):245-254. PubMed ID: 34686782 [TBL] [Abstract][Full Text] [Related]
19. Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer's Disease. Rasool M; Malik A; Waquar S; Zaheer A; Asif M; Iqbal Z; Gauthaman K; Kamal MA; Pushparaj PN CNS Neurol Disord Drug Targets; 2021; 20(7):602-612. PubMed ID: 33583389 [TBL] [Abstract][Full Text] [Related]
20. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. de la Monte SM Curr Alzheimer Res; 2012 Jan; 9(1):35-66. PubMed ID: 22329651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]